Radical Hypofractionated Radiotherapy for Localized Prostate Cancer

Exclusion Criteria

• •Patients who have received any other early treatment for prostate cancer, including radiotherapy, chemotherapy, focal therapy, etc;
• •a previous history of pelvic and abdominal radiotherapy;
• •Prior hormonal therapy (castration or antiandrogen);
• •Patients with other malignancies and acute or chronic infections such as human immunodeficiency virus (HIV) (+), hepatitis C virus (HCV) (+) and/or positive syphilis;
• •Patients that the investigator considers unsuitable to participate in the clinical trial; patients with other serious systemic diseases, evaluation and compliance of the trial, including severe respiratory, circulatory, neurological, mental, digestive, endocrine, immune, urinary, and other systemic diseases;
• •Patients with contraindications related to radiotherapy;
• •Participate in other clinical trials that are mutually exclusive with the study intervention within 4 weeks prior to the start of the study;
• •Patients unable to provide written informed consent or demonstrate poor treatment compliance